Matches in Wikidata for { <http://www.wikidata.org/entity/Q91576333> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q91576333 description "article scientifique publié en 2019" @default.
- Q91576333 description "artículu científicu espublizáu en setiembre de 2019" @default.
- Q91576333 description "scientific article published on 01 September 2019" @default.
- Q91576333 description "wetenschappelijk artikel" @default.
- Q91576333 description "наукова стаття, опублікована 1 вересня 2019" @default.
- Q91576333 name "PTEN loss is a predictive marker for HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies" @default.
- Q91576333 name "PTEN loss is a predictive marker for HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies" @default.
- Q91576333 type Item @default.
- Q91576333 label "PTEN loss is a predictive marker for HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies" @default.
- Q91576333 label "PTEN loss is a predictive marker for HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies" @default.
- Q91576333 prefLabel "PTEN loss is a predictive marker for HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies" @default.
- Q91576333 prefLabel "PTEN loss is a predictive marker for HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies" @default.
- Q91576333 P1433 Q91576333-7084A22D-316B-46D1-9D02-E9B9BE02BD78 @default.
- Q91576333 P1476 Q91576333-0777FFBB-68C8-472B-AF9B-2FC43AF6377A @default.
- Q91576333 P2093 Q91576333-0E9C899A-B1E9-4F57-B288-7911A23DB580 @default.
- Q91576333 P2093 Q91576333-551B8FB7-ED19-48E9-8521-3823ED007FE1 @default.
- Q91576333 P2093 Q91576333-5B6C8F1F-2C8F-4DAB-90AD-3E4559C0CFDE @default.
- Q91576333 P2093 Q91576333-6E09A173-DFA5-495B-9C71-933BF25E86A7 @default.
- Q91576333 P2093 Q91576333-B0A241A2-A4CA-413B-AFA9-C421C2CB2A2A @default.
- Q91576333 P2093 Q91576333-C9263652-BD1A-4245-8432-AD6A183D6708 @default.
- Q91576333 P2093 Q91576333-D2DC2EE2-619A-4229-A80D-EB41AA1CEAD3 @default.
- Q91576333 P304 Q91576333-19A55ECD-054D-489B-BED2-877DFACEE800 @default.
- Q91576333 P31 Q91576333-CB520230-FF5C-423F-917F-8545B76B7747 @default.
- Q91576333 P433 Q91576333-0EA351C0-4542-41EB-A9C7-ADB5AF9A2CD9 @default.
- Q91576333 P478 Q91576333-260671BD-3917-4685-8143-9AD65EA7BB0C @default.
- Q91576333 P577 Q91576333-3CD1312B-FA87-4A2E-9491-FD0BF322A500 @default.
- Q91576333 P698 Q91576333-9A99DCDC-F614-4981-BCE6-E9208BF8C53D @default.
- Q91576333 P921 Q91576333-08CC938D-C589-46B5-86A3-21266E000103 @default.
- Q91576333 P698 31786856 @default.
- Q91576333 P1433 Q27721148 @default.
- Q91576333 P1476 "PTEN loss is a predictive marker for HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies" @default.
- Q91576333 P2093 "Deniz Tural" @default.
- Q91576333 P2093 "Emre Akar" @default.
- Q91576333 P2093 "Kemal Tekesin" @default.
- Q91576333 P2093 "Mehmet Emin Gunes" @default.
- Q91576333 P2093 "Savas Bayrak" @default.
- Q91576333 P2093 "Serdar Altinay" @default.
- Q91576333 P2093 "Tulin Ozturk" @default.
- Q91576333 P304 "1920-1926" @default.
- Q91576333 P31 Q13442814 @default.
- Q91576333 P433 "5" @default.
- Q91576333 P478 "24" @default.
- Q91576333 P577 "2019-09-01T00:00:00Z" @default.
- Q91576333 P698 "31786856" @default.
- Q91576333 P921 Q12859063 @default.